Kodiak Sciences Inc.

Kodiak Sciences is a biotechnology company developing experimental medicines to treat diseases of the retina, the light-sensitive tissue at the back of the eye. The company's main product candidate is an antibody called tarcocimab tedromer, which is being tested in clinical trials for conditions like diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. These diseases can cause vision loss and blindness. Kodiak is also working on earlier-stage experimental treatments that target inflammation and blood vessel growth in the eye.